Publicaciones en las que colabora con Miguel Ángel Piris Pinilla (20)

2023

  1. NanoString analysis of mycosis fungoides reveals individual molecular identity

    British Journal of Dermatology

2022

  1. PLCγ1/PKCθ Downstream Signaling Controls Cutaneous T-Cell Lymphoma Development and Progression

    Journal of Investigative Dermatology, Vol. 142, Núm. 5, pp. 1391-1400.e15

2018

  1. Mycosis fungoides progression could be regulated by microRNAs

    PLoS ONE, Vol. 13, Núm. 6

2017

  1. Shared Oncogenic Pathways Implicated in Both Virus-Positive and UV-Induced Merkel Cell Carcinomas

    Journal of Investigative Dermatology, Vol. 137, Núm. 1, pp. 197-206

2016

  1. Erratum to Individualized strategies to target specific mechanisms of disease in malignant melanoma patients displaying unique mutational signatures [Oncotarget, (2015), 6, 25452-25465] Doi: 10.18632/oncotarget.4545

    Oncotarget

2015

  1. Individualized strategies to target specific mechanisms of disease in malignant melanoma patients displaying unique mutational signatures

    Oncotarget, Vol. 6, Núm. 28, pp. 25452-25465

  2. Mutated JAK kinases and deregulated STAT activity are potential therapeutic targets in cutaneous T-cell lymphoma

    Haematologica

2014

  1. PIM kinases as potential therapeutic targets in a subset of peripheral T cell lymphoma cases

    PLoS ONE, Vol. 9, Núm. 11

  2. PLCG1 mutations in cutaneous T-cell lymphomas

    Blood, Vol. 123, Núm. 13, pp. 2034-2043

2013

  1. Erratum: MicroRNAs as prognostic markers in indolent primary cutaneous B-cell lymphoma (Modern Pathology (2012) DOI; 10.1038/modpathol.2012.149)

    Modern Pathology

  2. MicroRNAs as prognostic markers in indolent primary cutaneous B-cell lymphoma

    Modern Pathology, Vol. 26, Núm. 2, pp. 171-181

  3. NIK controls classical and alternative NF-κB activation and is necessary for the survival of human T-cell lymphoma cells

    Clinical Cancer Research, Vol. 19, Núm. 9, pp. 2319-2330

  4. Simultaneous inhibition of pan-phosphatidylinositol-3-kinases and MEK as a potential therapeutic strategy in peripheral T-cell lymphomas

    Haematologica, Vol. 98, Núm. 1, pp. 57-64

  5. TCR-γ expression in primary cutaneous T-cell lymphomas

    American Journal of Surgical Pathology, Vol. 37, Núm. 3, pp. 375-384

2010

  1. Vorinostat interferes with the signaling transduction pathway of T-cell receptor and synergizes with phosphoinositide-3 kinase inhibitors in cutaneous T-cell lymphoma

    Haematologica, Vol. 95, Núm. 4, pp. 613-621

2009

  1. Psoralen plus ultraviolet A ± interferon-α treatment resistance in mycosis fungoides: The role of tumour microenvironment, nuclear transcription factor-κB and T-cell receptor pathways

    British Journal of Dermatology, Vol. 160, Núm. 1, pp. 92-102

  2. Targeted Activation of Innate Immunity for Therapeutic Induction of Autophagy and Apoptosis in Melanoma Cells

    Cancer Cell, Vol. 16, Núm. 2, pp. 103-114

2004

  1. Posible implicación de las alteraciones moleculares de la vía de TNF en la tumorigénesis de la micosis fungoide. Descripción de un posible chip de diagnóstico molecular en micosis fungoide

    Actas Dermo-Sifiliograficas, Vol. 95, Núm. 2, pp. 86-96

2002

  1. p16INK4a is selectively silenced in the tumoral progression of mycosis fungoides

    Laboratory Investigation, Vol. 82, Núm. 2, pp. 123-132

2000

  1. p16INK4a gene alterations are frequent in lesions of mycosis fungoides

    American Journal of Pathology, Vol. 156, Núm. 5, pp. 1565-1572